Alliancebernstein L.P. Buys 128,041 Shares of Integra LifeSciences Holdings Corporation $IART

Alliancebernstein L.P. lifted its holdings in shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART - Free Report) by 5.0% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,706,434 shares of the life sciences company's stock after acquiring an additional 128,041 shares during the quarter. Alliancebernstein L.P. owned 3.48% of Integra LifeSciences worth $59,514,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of IART. Principal Financial Group Inc. grew its holdings in Integra LifeSciences by 2.5% during the first quarter. Principal Financial Group Inc. now owns 433,924 shares of the life sciences company's stock valued at $9,542,000 after purchasing an additional 10,492 shares during the period. Wealth Enhancement Advisory Services LLC bought a new position in Integra LifeSciences during the first quarter valued at $251,000. Victory Capital Management Inc. grew its holdings in Integra LifeSciences by 1,067.6% during the first quarter. Victory Capital Management Inc. now owns 147,982 shares of the life sciences company's stock valued at $3,254,000 after purchasing an additional 135,308 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in Integra LifeSciences by 3.9% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 38,466 shares of the life sciences company's stock valued at $872,000 after purchasing an additional 1,437 shares during the period. Finally, GAMMA Investing LLC grew its holdings in Integra LifeSciences by 3,595.1% during the first quarter. GAMMA Investing LLC now owns 23,353 shares of the life sciences company's stock valued at $5,140,000 after purchasing an additional 22,721 shares during the period. 84.78% of the stock is owned by hedge funds and other institutional investors.

Integra LifeSciences Stock Performance

NASDAQ IART traded down $0.10 on Thursday, hitting $15.30. 993,900 shares of the stock traded hands, compared to its average volume of 1,051,176. The business's fifty day moving average is $13.54 and its two-hundred day moving average is $15.65. Integra LifeSciences Holdings Corporation has a 12 month low of $11.06 and a 12 month high of $27.13. The firm has a market capitalization of $1.19 billion, a price-to-earnings ratio of -2.34, a PEG ratio of 0.87 and a beta of 1.20. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.73 and a current ratio of 1.23.

Integra LifeSciences (NASDAQ:IART - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The life sciences company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.02. Integra LifeSciences had a positive return on equity of 12.15% and a negative net margin of 30.87%.The business had revenue of $415.61 million during the quarter, compared to analyst estimates of $395.06 million. During the same period in the prior year, the company earned $0.63 earnings per share. Integra LifeSciences's revenue was down .6% compared to the same quarter last year. Integra LifeSciences has set its FY 2025 guidance at 2.190-2.290 EPS. Q3 2025 guidance at 0.400-0.450 EPS. As a group, equities analysts anticipate that Integra LifeSciences Holdings Corporation will post 2.45 EPS for the current fiscal year.

Integra LifeSciences Company Profile

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services.